261 related articles for article (PubMed ID: 38400041)
1. The Importance of Lassa Fever and Its Disease Management in West Africa.
Reyna RA; Littlefield KE; Shehu N; Makishima T; Maruyama J; Paessler S
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400041
[TBL] [Abstract][Full Text] [Related]
2. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.
Mateer EJ; Huang C; Shehu NY; Paessler S
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486
[TBL] [Abstract][Full Text] [Related]
3. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
4. The search for animal models for Lassa fever vaccine development.
Lukashevich IS
Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
[TBL] [Abstract][Full Text] [Related]
5. Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection.
Yun NE; Ronca S; Tamura A; Koma T; Seregin AV; Dineley KT; Miller M; Cook R; Shimizu N; Walker AG; Smith JN; Fair JN; Wauquier N; Bockarie B; Khan SH; Makishima T; Paessler S
J Virol; 2015 Dec; 90(6):2920-7. PubMed ID: 26719273
[TBL] [Abstract][Full Text] [Related]
6. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK;
PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258
[TBL] [Abstract][Full Text] [Related]
7. Lassa fever - the road ahead.
Garry RF
Nat Rev Microbiol; 2023 Feb; 21(2):87-96. PubMed ID: 36097163
[TBL] [Abstract][Full Text] [Related]
8. Advanced vaccine candidates for Lassa fever.
Lukashevich IS
Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493
[TBL] [Abstract][Full Text] [Related]
9. Lassa virus diversity and feasibility for universal prophylactic vaccine.
Lukashevich IS; Paessler S; de la Torre JC
F1000Res; 2019; 8():. PubMed ID: 30774934
[TBL] [Abstract][Full Text] [Related]
10. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
[TBL] [Abstract][Full Text] [Related]
11. Vaccine platforms to control Lassa fever.
Lukashevich IS; Pushko P
Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
[TBL] [Abstract][Full Text] [Related]
12. Lassa fever vaccine use cases and demand: Perspectives from select West African experts.
Kaboré L; Pecenka C; Hausdorff WP
Vaccine; 2024 Mar; 42(8):1873-1877. PubMed ID: 38369392
[TBL] [Abstract][Full Text] [Related]
13. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
[TBL] [Abstract][Full Text] [Related]
15. Identification of Common CD8
Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
[TBL] [Abstract][Full Text] [Related]
16. A review of Lassa fever vaccine candidates.
Salami K; Gouglas D; Schmaljohn C; Saville M; Tornieporth N
Curr Opin Virol; 2019 Aug; 37():105-111. PubMed ID: 31472333
[TBL] [Abstract][Full Text] [Related]
17. Vaccine platforms for the prevention of Lassa fever.
Purushotham J; Lambe T; Gilbert SC
Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.
Murphy HL; Ly H
Virulence; 2021 Dec; 12(1):2989-3014. PubMed ID: 34747339
[TBL] [Abstract][Full Text] [Related]
19. Understanding the cryptic nature of Lassa fever in West Africa.
Gibb R; Moses LM; Redding DW; Jones KE
Pathog Glob Health; 2017 Sep; 111(6):276-288. PubMed ID: 28875769
[TBL] [Abstract][Full Text] [Related]
20. The niche of One Health approaches in Lassa fever surveillance and control.
Arruda LB; Haider N; Olayemi A; Simons D; Ehichioya D; Yinka-Ogunleye A; Ansumana R; Thomason MJ; Asogun D; Ihekweazu C; Fichet-Calvet E; Kock RA
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):29. PubMed ID: 33894784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
